Mannose 6 phosphorylation of lysosomal enzymes controls B cell functions

Journal of Cell Biology

Volumn 208, Issue 2, 2015, Pages 171-180

  Otomo, Takanobu ^a,b   Schweizer, Michaela ^a   Kollmann, Katrin ^a   Schumacher, Valéa ^a   Muschol, Nicole ^a   Tolosa, Eva ^a   Mittrücker, Hans Willi ^a   Braulke, Thomas ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CATHEPSIN B; CATHEPSIN L; CD27 ANTIGEN; CD74 ANTIGEN; GAMMA INTERFERON; GRANZYME A; GRANZYME B; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; LYSOSOME ENZYME; MANNOSE 6 PHOSPHATE; SYNDECAN 1; TUMOR NECROSIS FACTOR; GNPTAB PROTEIN, MOUSE; MANNOSE PHOSPHATE; MANNOSE-6-PHOSPHATE; PEPTIDE HYDROLASE; PHOSPHOTRANSFERASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INTERACTION; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DISULFIDE BOND; DOWN REGULATION; ENDOCYTOSIS; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GAMMA DELTA T LYMPHOCYTE; HELPER CELL; HOMEOSTASIS; HUMAN; HUMAN CELL; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN PRODUCTION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; LYSOSOME; MEMORY CELL; MOUSE; MUCOLIPIDOSIS TYPE 2; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN TRANSPORT; UBIQUITINATION; ANIMAL; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; ENZYMOLOGY; GENETICS; IMMUNOLOGY; METABOLISM; MUCOLIPIDOSIS; PHOSPHORYLATION; PROTEIN PROCESSING; T LYMPHOCYTE; TRANSGENIC MOUSE;

MUS;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS; B-LYMPHOCYTES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; DENDRITIC CELLS; HUMANS; LYSOSOMES; MANNOSEPHOSPHATES; MICE, TRANSGENIC; MUCOLIPIDOSES; PEPTIDE HYDROLASES; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; T-LYMPHOCYTES; TRANSFERASES (OTHER SUBSTITUTED PHOSPHATE GROUPS);

EID: 84921737623     PISSN: 00219525     EISSN: 15408140     Source Type: Journal    
DOI: 10.1083/jcb.201407077     Document Type: Article

References (46)

1. Bao, M., B.J. Elmendorf, J.L. Booth, R.R. Drake, and W.M. Canfield. 1996. Bovine UDP-N-acetylglucosamine:lysosomal-enzyme N-acetylglucosamine-1-phosphotransferase. II. Enzymatic characterization and identification of the catalytic subunit. J. Biol. Chem. 271: 31446-31451. http://dx.doi.org/10.1074/jbc.271.49.31446
2. Barnden, M.J., J. Allison, W.R. Heath, and F.R. Carbone. 1998. Defective TCR expression in transgenic mice constructed using cDNA-based α- and β-chain genes under the control of heterologous regulatory elements. Immunol. Cell Biol. 76: 34-40. http://dx.doi.org/10.1046/j.1440-1711.1998.00709.x
3. Braulke, T., and J.S. Bonifacino. 2009. Sorting of lysosomal proteins. Biochim. Biophys. Acta 1793: 605-614. http://dx.doi.org/10.1016/j.bbamcr.2008.10.016
4. Braulke, T., A. Raas-Rothschild, and S. Kornfeld. 2013. I-Cell Disease and Pseudo-Hurler Polydystrophy: Disorders of Lysosomal Enzyme Phosphorylation and Localization. In The Online Metabolic and Molecular Bases of Inherited Disease. D. Valle, A.L. Beaudet, B. Vogelstein, K.W. Kinzler, S.E. Antonarakis, A. Ballabio, C. Scriver, B. Childs, W. Sly, F. Bunz, K.M. Gibson, G. Mitchell, editors. McGraw Hill, New York. Chapter 138.
5. Comans-Bitter, W.M., R. de Groot, R. van den Beemd, H.J. Neijens, W.C. Hop, K. Groeneveld, H. Hooijkaas, and J.J. van Dongen. 1997. Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulations. J. Pediatr. 130: 388-393. http://dx.doi.org/10.1016/S0022-3476(97)70200-2
6. Daly, T.M., R.G. Lorenz, and M.S. Sands. 2000. Abnormal immune function in vivo in a murine model of lysosomal storage disease. Pediatr. Res. 47: 757-762. http://dx.doi.org/10.1203/00006450-200006000-00012
7. Delamarre, L., M. Pack, H. Chang, I. Mellman, and E.S. Trombetta. 2005. Differential lysosomal proteolysis in antigen-presenting cells determines antigen fate. Science307: 1630-1634. http://dx.doi.org/10.1126/science.1108003
8. Delamarre, L., R. Couture, I. Mellman, and E.S. Trombetta. 2006. Enhancing immunogenicity by limiting susceptibility to lysosomal proteolysis. J. Exp. Med. 203: 2049-2055. http://dx.doi.org/10.1084/jem.20052442
9. Desnick, R.J., H.L. Sharp, G.A. Grabowski, R.D. Brunning, P.G. Quie, J.H. Sung, R.J. Gorlin, and J.U. Ikonne. 1976. Mannosidosis: clinical, morphologic, immunologic, and biochemical studies. Pediatr. Res. 10: 985-996. http://dx.doi.org/10.1203/00006450-197612000-00008
10. Donaldson, J.G., D. Finazzi, and R.D. Klausner. 1992. Brefeldin A inhibits Golgi membrane-catalysed exchange of guanine nucleotide onto ARF protein. Nature360: 350-352. http://dx.doi.org/10.1038/360350a0
11. Driessen, C., R.A. Bryant, A.M. Lennon-Duménil, J.A. Villadangos, P.W. Bryant, G.P. Shi, H.A. Chapman, and H.L. Ploegh. 1999. Cathepsin S controls the trafficking and maturation of MHC class II molecules in dendritic cells. J. Cell Biol. 147: 775-790. http://dx.doi.org/10.1083/jcb.147.4.775
12. Fairfax, K.A., A. Kallies, S.L. Nutt, and D.M. Tarlinton. 2008. Plasma cell development: from B-cell subsets to long-term survival niches. Semin. Immunol. 20: 49-58. http://dx.doi.org/10.1016/j.smim.2007.12.002
13. Fratantoni, J.C., C.W. Hall, and E.F. Neufeld. 1969. The defect in Hurler and Hunter syndromes. II. Deficiency of specific factors involved in mucopolysaccharide degradation. Proc. Natl. Acad. Sci. USA64: 360-366. http://dx.doi.org/10.1073/pnas.64.1.360
14. Furuta, K., E. Walseng, and P.A. Roche. 2013. Internalizing MHC class II-peptide complexes are ubiquitinated in early endosomes and targeted for lysosomal degradation. Proc. Natl. Acad. Sci. USA110: 20188-20193. http://dx.doi.org/10.1073/pnas.1312994110
15. Glickman, J.N., and S. Kornfeld. 1993. Mannose 6-phosphate-independent targeting of lysosomal enzymes in I-cell disease B lymphoblasts. J. Cell Biol. 123: 99-108. http://dx.doi.org/10.1083/jcb.123.1.99
16. Griffiths, G.M., and S. Isaaz. 1993. Granzymes A and B are targeted to the lytic granules of lymphocytes by the mannose-6-phosphate receptor. J. Cell Biol. 120: 885-896. http://dx.doi.org/10.1083/jcb.120.4.885
17. Honey, K., and A.Y. Rudensky. 2003. Lysosomal cysteine proteases regulate antigen presentation. Nat. Rev. Immunol. 3: 472-482. http://dx.doi.org/10.1038/nri1110
18. Inaba, K., W.J. Swiggard, R.M. Steinman, N. Romani, G. Schuler, and C. Brinster. 2009. Isolation of dendritic cells. Curr. Protoc. Immunol. Chapter 3:Unit 3.7.
19. Karageorgos, L.E., E.L. Isaac, D.A. Brooks, E.M. Ravenscroft, R. Davey, J.J. Hopwood, and P.J. Meikle. 1997. Lysosomal biogenesis in lysosomal storage disorders. Exp. Cell Res. 234: 85-97. http://dx.doi.org/10.1006/excr.1997.3581
20. Kojima, S., S. Okada, H. Kai, K. Ha, O. Nose, T. Ikeda, T. Yutaka, M. Kato, and H. Yabuuchi. 1979. A case of mucolipidosis II: Biochemical, nutritional, and immunological studies. Brain Dev. 1: 26-30. http://dx.doi.org/10.1016/S0387-7604(79)80031-5
21. Kollmann, K., M. Damme, S. Markmann, W. Morelle, M. Schweizer, I. Hermans-Borgmeyer, A.K. Röchert, S. Pohl, T. Lübke, J.C. Michalski, et al. 2012. Lysosomal dysfunction causes neurodegeneration in mucolipidosis II 'knock-in' mice. Brain135: 2661-2675. http://dx.doi.org/10.1093/brain/aws209
22. Kollmann, K., J.M. Pestka, S.C. Kühn, E. Schöne, M. Schweizer, K. Karkmann, T. Otomo, P. Catala-Lehnen, A.V. Failla, R.P. Marshall, et al. 2013. Decreased bone formation and increased osteoclastogenesis cause bone loss in mucolipidosis II. EMBO Mol. Med. 5: 1871-1886. http://dx.doi.org/10.1002/emmm.201302979
23. Kudo, M., M. Bao, A. D'Souza, F. Ying, H. Pan, B.A. Roe, and W.M. Canfield. 2005. The α- and β-subunits of the human UDP-N-acetylglucosamine: lysosomal enzyme N-acetylglucosamine-1-phosphotransferase [corrected] are encoded by a single cDNA. J. Biol. Chem. 280: 36141-36149. http://dx.doi.org/10.1074/jbc.M509008200
24. Little, L., M. Alcouloumre, A.M. Drotar, S. Herman, R. Robertson, R.Y. Yeh, and A.L. Miller. 1987. Properties of N-acetylglucosamine 1-phosphotransferase from human lymphoblasts. Biochem. J. 248:151-159.
25. Ma, J.K., M.Y. Platt, J. Eastham-Anderson, J.S. Shin, and I. Mellman. 2012. MHC class II distribution in dendritic cells and B cells is determined by ubiquitin chain length. Proc. Natl. Acad. Sci. USA109: 8820-8827. http://dx.doi.org/10.1073/pnas.1202977109
26. Malm, D., D.S. Halvorsen, L. Tranebjaerg, and H. Sjursen. 2000. Immunodeficiency in α-mannosidosis: a matched case-control study on immunoglobulins, complement factors, receptor density, phagocytosis and intracellular killing in leucocytes. Eur. J. Pediatr. 159: 699-703. http://dx.doi.org/10.1007/s004310000545
27. Maric, M., B. Arunachalam, U.T. Phan, C. Dong, W.S. Garrett, K.S. Cannon, C. Alfonso, L. Karlsson, R.A. Flavell, and P. Cresswell. 2001. Defective antigen processing in GILT-free mice. Science294: 1361-1365. http://dx.doi.org/10.1126/science.1065500
28. Morbach, H., E.M. Eichhorn, J.G. Liese, and H.J. Girschick. 2010. Reference values for B cell subpopulations from infancy to adulthood. Clin. Exp. Immunol. 162: 271-279. http://dx.doi.org/10.1111/j.1365-2249.2010.04206.x
29. Nakagawa, T., W. Roth, P. Wong, A. Nelson, A. Farr, J. Deussing, J.A. Villadangos, H. Ploegh, C. Peters, and A.Y. Rudensky. 1998. Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus. Science280: 450-453. http://dx.doi.org/10.1126/science.280.5362.450
30. Nakagawa, T.Y., W.H. Brissette, P.D. Lira, R.J. Griffiths, N. Petrushova, J. Stock, J.D. McNeish, S.E. Eastman, E.D. Howard, S.R. Clarke, et al. 1999. Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice. Immunity10: 207-217. http://dx.doi.org/10.1016/S1074-7613(00)80021-7
31. Otomo, T., T. Muramatsu, T. Yorifuji, T. Okuyama, H. Nakabayashi, T. Fukao, T. Ohura, M. Yoshino, A. Tanaka, N. Okamoto, et al. 2009. Mucolipidosis II and III α/β: mutation analysis of 40 Japanese patients showed genotype-phenotype correlation. J. Hum. Genet. 54: 145-151. http://dx.doi.org/10.1038/jhg.2009.3
32. Owada, M., and E.F. Neufeld. 1982. Is there a mechanism for introducing acid hydrolases into liver lysosomes that is independent of mannose 6-phosphate recognition? Evidence from I-cell disease. Biochem. Biophys. Res. Commun. 105: 814-820. http://dx.doi.org/10.1016/0006-291X(82)91042-7
33. Peters, M.E., S. Arya, L.O. Langer, E.F. Gilbert, R. Carlson, and W. Adkins. 1985. Narrow trachea in mucopolysaccharidoses. Pediatr. Radiol. 15: 225-228. http://dx.doi.org/10.1007/BF02388760
34. Raas-Rothschild, A., V. Cormier-Daire, M. Bao, E. Genin, R. Salomon, K. Brewer, M. Zeigler, H. Mandel, S. Toth, B. Roe, et al. 2000. Molecular basis of variant pseudo-hurler polydystrophy (mucolipidosis IIIC). J. Clin. Invest. 105: 673-681. http://dx.doi.org/10.1172/JCI5826
35. Reitman, M.L., A. Varki, and S. Kornfeld. 1981. Fibroblasts from patients with I-cell disease and pseudo-Hurler polydystrophy are deficient in uridine 5'-diphosphate-N-acetylglucosamine: glycoprotein N-acetylglucosaminylphosphotransferase activity. J. Clin. Invest. 67: 1574-1579. http://dx.doi.org/10.1172/JCI110189
36. Riese, R.J., R.N. Mitchell, J.A. Villadangos, G.P. Shi, J.T. Palmer, E.R. Karp, G.T. De Sanctis, H.L. Ploegh, and H.A. Chapman. 1998. Cathepsin S activity regulates antigen presentation and immunity. J. Clin. Invest. 101: 2351-2363. http://dx.doi.org/10.1172/JCI1158
37. Roche, P.A., and P. Cresswell. 1991. Proteolysis of the class II-associated invariant chain generates a peptide binding site in intracellular HLA-DR molecules. Proc. Natl. Acad. Sci. USA88: 3150-3154. http://dx.doi.org/10.1073/pnas.88.8.3150
38. Saftig, P., and J. Klumperman. 2009. Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function. Nat. Rev. Mol. Cell Biol. 10: 623-635. http://dx.doi.org/10.1038/nrm2745
39. Sawkar, A.R., W. D'Haeze, and J.W. Kelly. 2006. Therapeutic strategies to ameliorate lysosomal storage disorders-a focus on Gaucher disease. Cell. Mol. Life Sci. 63: 1179-1192. http://dx.doi.org/10.1007/s00018-005-5437-0
40. Schägger, H. 2006. Tricine-SDS-PAGE. Nat. Protoc. 1: 16-22. http://dx.doi.org/10.1038/nprot.2006.4
41. Schröder, B.A., C. Wrocklage, A. Hasilik, and P. Saftig. 2010. The proteome of lysosomes. Proteomics10: 4053-4076. http://dx.doi.org/10.1002/pmic.201000196
42. Stiehm, E.R., and H.H. Fudenberg. 1966. Serum levels of immune globulins in health and disease: a survey. Pediatrics37: 715-727. Tiede, S., S. Storch, T. Lübke, B. Henrissat, R. Bargal, A. Raas-Rothschild, and
43. T. Braulke. 2005. Mucolipidosis II is caused by mutations in GNPTA encoding the α/β GlcNAc-1-phosphotransferase. Nat. Med. 11: 1109-1112. http://dx.doi.org/10.1038/nm1305
44. Tsuji, A., K. Omura, and Y. Suzuki. 1988. I-cell disease: evidence for a mannose 6-phosphate independent pathway for translocation of lysosomal enzymes in lymphoblastoid cells. Clin. Chim. Acta176: 115-121. http://dx.doi.org/10.1016/0009-8981(88)90181-7
45. Waheed, A., R. Pohlmann, A. Hasilik, and K. von Figura. 1981. Subcellular location of two enzymes involved in the synthesis of phosphorylated recognition markers in lysosomal enzymes. J. Biol. Chem. 256:4150-4152.
46. Waheed, A., R. Pohlmann, A. Hasilik, K. von Figura, A. van Elsen, and J.G. Leroy. 1982. Deficiency of UDP-N-acetylglucosamine:lysosomal enzyme N-acetylglucosamine-1-phosphotransferase in organs of I-cell patients. Biochem. Biophys. Res. Commun. 105: 1052-1058. http://dx.doi.org/10.1016/0006-291X(82)91076-2